In addition to delivering low-molecular-weight chemotherapy drugs, NPs can also be effective carriers of other molecules that inhibit tumor cell growth and survival––ribosome-inactivating proteins [56] and small interfering RNAs [57] that aim to knock out the gene encoding galectin-1 in glioblastoma cells. Here, LGALS1 is linked to neoplasm.